Ruilaipu (Hangzhou) Medical Technology Co., Ltd.
PrivateLast Round
Series B
Sep 26, 2024
Total Funding Raised
$14.4M
Company Overview
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series B round in September 2024.
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is a medical technology company that develops high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) detection systems and automated sample pretreatment platforms for clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Comparables
Compare Ruilaipu (Hangzhou) Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Reigncom Biotech Co., Ltd. | 89% | |
| Hangzhou Calibra Diagnostics Co., Ltd. | 87% | |
| Hangzhou Well-healthcare Technologies Co., Ltd. | 87% |
For institutional investors. Book with your work email.
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 26, 2024 | ||||
| Series A Extension | Feb 6, 2023 | ||||
| Series A Extension | Mar 31, 2022 | ||||
| Series A Extension | May 31, 2021 | ||||
| Series A | Dec 18, 2020 | ||||
Angel | Oct 1, 2019 |
For institutional investors. Book with your work email.
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 3H Health Investment | Series A Extension |
| Legend Capital | Series A Extension, Series A |
| Guangzhou Industrial Investment Holding Group | Series B |
| 辰德资本 | Series A Extension, Series B, Series A, Angel |
| Vinno Capital | Series B |
| Huagai Capital | Series A, Series A Extension |
| CPE | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 31, 2021
Led by 3H Health Investment with participation from Huagai Capital, Legend Capital, and 辰德资本.
- Dec 18, 2020
Raised Series A with Huagai Capital, Legend Capital, and 辰德资本.
For institutional investors. Book with your work email.
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Ruilaipu (Hangzhou) Medical Technology Co., Ltd. a public or private company?
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is a private company.
What is the current stock price of Ruilaipu (Hangzhou) Medical Technology Co., Ltd.?
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ruilaipu (Hangzhou) Medical Technology Co., Ltd. worth (valuation)?
Valuation information for Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is not publicly available.
Can I buy Ruilaipu (Hangzhou) Medical Technology Co., Ltd. stock?
Ruilaipu (Hangzhou) Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s last funding round?
Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s most recent funding round was Series B on September 26, 2024.
Who are the main investors in Ruilaipu (Hangzhou) Medical Technology Co., Ltd.?
Key investors in Ruilaipu (Hangzhou) Medical Technology Co., Ltd. include 3H Health Investment, CPE.
Will Ruilaipu (Hangzhou) Medical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Ruilaipu (Hangzhou) Medical Technology Co., Ltd..
How can I track Ruilaipu (Hangzhou) Medical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s shares on secondary markets.